Published in Antimicrob Agents Chemother on August 01, 2008
Detection of resistance mutations to antivirals oseltamivir and zanamivir in avian influenza A viruses isolated from wild birds. PLoS One (2011) 1.43
Oseltamivir in seasonal influenza: cumulative experience in low- and high-risk patients. J Antimicrob Chemother (2010) 1.15
The status of pharmacometrics in pregnancy: highlights from the 3(rd) American conference on pharmacometrics. Br J Clin Pharmacol (2012) 1.07
Acute encephalopathy associated with influenza A infection in adults. Emerg Infect Dis (2010) 0.94
Synaptic and behavioral interactions of oseltamivir (Tamiflu) with neurostimulants. Hum Exp Toxicol (2008) 0.80
A Critical Role for Immune System Response in Mediating Anti-influenza Drug Synergies Assessed by Mechanistic Modeling. CPT Pharmacometrics Syst Pharmacol (2014) 0.79
Nonclinical pharmacokinetics of oseltamivir and oseltamivir carboxylate in the central nervous system. Antimicrob Agents Chemother (2009) 0.79
How to approach and treat viral infections in ICU patients. BMC Infect Dis (2014) 0.77
Serial CSF sampling over a period of 30 h via an indwelling spinal catheter in healthy volunteers: headache, back pain, tolerability and measured acetylcholine profile. Eur J Clin Pharmacol (2012) 0.76
Evaluation of [(11)C]oseltamivir uptake into the brain during immune activation by systemic polyinosine-polycytidylic acid injection: a quantitative PET study using juvenile monkey models of viral infection. EJNMMI Res (2014) 0.75
Acute influenza virus-associated encephalitis and encephalopathy in adults: a challenging diagnosis. JMM Case Rep (2016) 0.75
Role of the ABCB1 Drug Transporter Polymorphisms in the Pharmacokinetics of Oseltamivir in Humans: a Preliminary Report. J Korean Med Sci (2017) 0.75
Neuraminidase inhibitors for influenza. N Engl J Med (2005) 7.79
Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet (2000) 5.03
Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J (2001) 4.93
Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis. J Infect Dis (2004) 4.31
Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802. Clin Pharmacokinet (1999) 3.61
Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population. J Am Geriatr Soc (2001) 2.67
Anti-influenza prodrug oseltamivir is activated by carboxylesterase human carboxylesterase 1, and the activation is inhibited by antiplatelet agent clopidogrel. J Pharmacol Exp Ther (2006) 2.49
Development of a high-performance liquid chromatographic-mass spectrometric assay for the specific and sensitive quantification of Ro 64-0802, an anti-influenza drug, and its pro-drug, oseltamivir, in human and animal plasma and urine. J Chromatogr B Biomed Sci Appl (2000) 2.16
The anti-influenza drug oseltamivir exhibits low potential to induce pharmacokinetic drug interactions via renal secretion-correlation of in vivo and in vitro studies. Drug Metab Dispos (2002) 1.36
Similarity in pharmacokinetics of oseltamivir and oseltamivir carboxylate in Japanese and Caucasian subjects. J Clin Pharmacol (2007) 1.30
Pharmacogenomics of the OATP and OAT families. Pharmacogenomics (2004) 1.21
Oseltamivir (Tamiflu) efflux transport at the blood-brain barrier via P-glycoprotein. Drug Metab Dispos (2007) 1.20
P-glycoprotein restricts the penetration of oseltamivir across the blood-brain barrier. Drug Metab Dispos (2007) 1.17
The safety of oseltamivir in patients with influenza: analysis of healthcare claims data from six influenza seasons. MedGenMed (2007) 1.16
Principles and applicability of CSF sampling for the assessment of CNS drug delivery and pharmacodynamics. Adv Drug Deliv Rev (2004) 1.15
Functional consequences of single nucleotide polymorphisms in the human organic anion transporter hOAT1 (SLC22A6). J Pharmacol Exp Ther (2005) 1.13
Contribution of organic anion transporter 3 (Slc22a8) to the elimination of p-aminohippuric acid and benzylpenicillin across the blood-brain barrier. J Pharmacol Exp Ther (2003) 1.08
Functional analysis of polymorphisms in the organic anion transporter, SLC22A6 (OAT1). Pharmacogenet Genomics (2005) 0.98
Oseltamivir and delirious behavior in children with influenza. Pediatr Infect Dis J (2006) 0.97
Serum levels of cytokines and EEG findings in children with influenza associated with mild neurological complications. Brain Dev (2007) 0.96
Genetic polymorphisms of ATP-binding cassette transporters ABCB1 and ABCG2: therapeutic implications. Expert Opin Pharmacother (2005) 0.95
Functional evaluation of ABCB1 (P-glycoprotein) polymorphisms: high-speed screening and structure-activity relationship analyses. Drug Metab Pharmacokinet (2004) 0.89
Delirious behavior in children with influenza: its clinical features and EEG findings. Brain Dev (2005) 0.87
Influenza A-associated central nervous system dysfunction in children presenting as transient visual hallucination. Pediatr Infect Dis J (2003) 0.86
Involvement of multiple transporters in the efflux of 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors across the blood-brain barrier. J Pharmacol Exp Ther (2004) 0.85
Neurologic manifestations in children with influenza B virus infection. Pediatr Infect Dis J (2006) 0.84
Analysis of oseltamivir active metabolite, oseltamivir carboxylate, in biological materials by HPLC-UV in a case of death following ingestion of Tamiflu. Leg Med (Tokyo) (2007) 0.81
Influenza B infection associated with encephalitis: treatment with oseltamivir. Pediatr Infect Dis J (2002) 0.81
Difficult Airway Society Guidelines for the management of tracheal extubation. Anaesthesia (2012) 7.19
Orbital and millennial Antarctic climate variability over the past 800,000 years. Science (2007) 5.10
Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys (1999) 4.72
The frequency of uterine leiomyomas. Am J Clin Pathol (1990) 4.00
ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor. Mod Pathol (2001) 3.55
Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey. Clin Pharmacol Ther (2012) 3.22
Randomized clinical trial of early laparoscopy in the management of acute non-specific abdominal pain. Br J Surg (1999) 3.18
Lyme arthritis in the Hunter Valley. Med J Aust (1982) 2.68
Microscopic satellitosis in patients with primary cutaneous melanoma: implications for nodal basin staging. Ann Surg Oncol (2009) 2.67
Cholesterol, coronary heart disease, and stroke in the Asia Pacific region. Int J Epidemiol (2003) 2.57
Contraction-induced changes in acetyl-CoA carboxylase and 5'-AMP-activated kinase in skeletal muscle. J Biol Chem (1997) 2.54
Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur Heart J (2002) 2.49
Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds. Diabetologia (2011) 2.28
Isolation of infectious human T-cell leukemia/lymphotropic virus type III (HTLV-III) from patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC) and from healthy carriers: a study of risk groups and tissue sources. Proc Natl Acad Sci U S A (1985) 2.26
Cardiovascular risk prediction tools for populations in Asia. J Epidemiol Community Health (2007) 2.25
Mild to moderate sleep respiratory events: one negative night may not be enough. Chest (2000) 2.23
Fewer sore throats and a better seal: why routine manometry for laryngeal mask airways must become the standard of care. Anaesthesia (2014) 2.21
A randomised controlled trial of cognitive behaviour therapy and motivational interviewing for people with Type 1 diabetes mellitus with persistent sub-optimal glycaemic control: a Diabetes and Psychological Therapies (ADaPT) study. Health Technol Assess (2010) 2.20
Nitric oxide synthase gene polymorphisms and diabetic nephropathy. Diabetologia (2003) 2.18
Complementary medicine: are patients' expectations being met by their general practitioners? Br J Gen Pract (1993) 2.18
Smoking, quitting, and the risk of cardiovascular disease among women and men in the Asia-Pacific region. Int J Epidemiol (2005) 2.16
Microdeletion 15q13.3: a locus with incomplete penetrance for autism, mental retardation, and psychiatric disorders. J Med Genet (2009) 2.13
Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration. Antimicrob Agents Chemother (2005) 1.98
Neutral-lipid storage disease: a new disorder of lipid metabolism. Br Med J (1975) 1.97
Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA. Science (1991) 1.93
Two distinct stages in the transition from naive CD4 T cells to effectors, early antigen-dependent and late cytokine-driven expansion and differentiation. J Immunol (2000) 1.92
A novel and rapid whole-blood assay for D-dimer in patients with clinically suspected deep vein thrombosis. Circulation (1995) 1.90
Mixed glioneuronal tumour of the fourth ventricle with prominent rosette formation. Neuropathol Appl Neurobiol (2006) 1.88
Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M. Science (1992) 1.85
Detection and direct genomic sequencing of multiple rare unknown flanking DNA in highly complex samples. Hum Gene Ther (2001) 1.83
Speed of onset of 'corner pocket supraclavicular' and infraclavicular ultrasound guided brachial plexus block: a randomised observer-blinded comparison. Anaesthesia (2009) 1.71
Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage. Lancet (1997) 1.65
Effects of monounsaturated fatty acids on glycaemic control in patients with abnormal glucose metabolism: a systematic review and meta-analysis. Ann Nutr Metab (2011) 1.65
Biochemical basis for fluorouracil neurotoxicity. The role of Krebs cycle inhibition by fluoroacetate. Arch Neurol (1970) 1.64
Expression of the herpes simplex virus type 2 latency-associated transcript enhances spontaneous reactivation of genital herpes in latently infected guinea pigs. J Exp Med (1995) 1.63
Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U-CH1. Genes Chromosomes Cancer (2001) 1.61
Hospital utilization patterns and costs for adult sickle cell patients in Illinois. Public Health Rep (1997) 1.60
Improved toluidine blue-DNA agar for detection of DNA hydrolysis by campylobacters. J Clin Microbiol (1987) 1.59
Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial. Diabetologia (2009) 1.59
Lens refilling and endocapsular polymerization of an injectable intraocular lens: in vitro and in vivo study of potential risks and benefits. J Cataract Refract Surg (1994) 1.58
The relationship between heparin level and activated clotting time in the adult cardiac surgery population. Perfusion (2009) 1.57
Serratia marcescens outbreak associated with extrinsic contamination of 1% chlorxylenol soap. Infect Control Hosp Epidemiol (1997) 1.56
Transtracheal jet ventilation in 50 patients with severe airway compromise and stridor. Br J Anaesth (2010) 1.56
A bacterial basic region leucine zipper histidine kinase regulating toluene degradation. Proc Natl Acad Sci U S A (1997) 1.55
Serotyping scheme for Staphylococcus aureus isolated from cows with mastitis. Am J Vet Res (1998) 1.55
Localization of impalpable breast lesions--a surgical approach. Eur J Surg Oncol (1996) 1.54
Multidisciplinary HIV adherence intervention: a randomized study. AIDS Patient Care STDS (2004) 1.54
A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate. Ann Rheum Dis (2004) 1.53
Use of antibiotic prophylaxis in elective inguinal hernia repair in adults in London and south-east England: a cross-sectional survey. Hernia (2013) 1.50
Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis. Arthritis Rheum (2000) 1.50
22q13.3 deletion syndrome: clinical and molecular analysis using array CGH. Am J Med Genet A (2010) 1.49
Ultrasound detection of extrahepatic encapsulated bile: "biloma". AJR Am J Roentgenol (1979) 1.48
Effects of flooding amino acids on incorporation of labeled amino acids into human muscle protein. Am J Physiol (1998) 1.47
Musculoskeletal involvement in cystic echinococcosis: report of eight cases and review of the literature. AJR Am J Roentgenol (1997) 1.47
Mice lacking transforming growth factor alpha have an increased susceptibility to dextran sulfate-induced colitis. Gastroenterology (1997) 1.46
Bilateral iridocorneal endothelial syndrome: case report and review of the literature. Cornea (1994) 1.45
Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging. Urology (2000) 1.44
Value of sonography in monitoring the therapeutic response of mediastinal lymphoma: comparison with chest radiography and CT. AJR Am J Roentgenol (1991) 1.44
[Water-filtered infrared-A (wIRA) promotes wound healing]. Chirurg (2014) 1.43
Furosemide-albumin complexes in refractory nephrotic syndrome and chronic renal failure. Nephron (1996) 1.42
Pollination mode in fig wasps: the predictive power of correlated traits. Proc Biol Sci (2001) 1.41
The lymphocyte Na+/H+ antiport: activation in primary hypertension and during chronic NaCl-loading. Eur J Clin Invest (1994) 1.41
[Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in patients in long-term care in hospitals, rehabilitation centers and nursing homes of a rural district in Germany]. Dtsch Med Wochenschr (2008) 1.41
The immunogenicity, safety, and efficacy of etanercept liquid administered once weekly in patients with rheumatoid arthritis. Clin Exp Rheumatol (2007) 1.41
The effect of temperature on bougies: a photographic and manikin study. Anaesthesia (2008) 1.40
Polycystic ovaries in patients with hypogonadotropic hypogonadism: similarity of ovarian response to gonadotropin stimulation in patients with polycystic ovarian syndrome. Fertil Steril (1992) 1.40
Applications of a new chemiluminometric thyrotropin assay to subnormal measurement. J Clin Endocrinol Metab (1990) 1.40
[Subarachnoid pleural fistula and subsequent pneumocephalus as complication of vertebral body replacement of the thoracic spine]. Unfallchirurg (2010) 1.39
Intra-operative frozen section analysis for suspected early-stage ovarian cancer: 11 years of Gateshead Cancer Centre experience. BJOG (2011) 1.39
Suppression of experimental autoimmune encephalomyelitis by sulfasalazine. Acta Neurol Scand (1990) 1.39
Calcium and extrapyramidal symptoms. Br J Psychiatry (1988) 1.38
Cyclic AMP-dependent synthesis of fimbriae in Salmonella typhimurium: effects of cya and pts mutations. J Bacteriol (1978) 1.38
Protective effect of epidermal growth factor in an experimental model of colitis in rats. Gastroenterology (1994) 1.37
Bronchodilator delivery in acute airflow obstruction. A meta-analysis. Arch Intern Med (1997) 1.37
Prospective observational study of acute coronary syndromes in China: practice patterns and outcomes. Heart (2007) 1.36
Randomized trial of an adherence programme for clients with HIV. Int J STD AIDS (2003) 1.36
P transposon-induced dominant enhancer mutations of position-effect variegation in Drosophila melanogaster. Genetics (1993) 1.35
Predictors of ovarian reserve in young women with breast cancer. Br J Cancer (2007) 1.35
Prototype development and preclinical immunogenicity analysis of a novel minimally invasive electroporation device. Gene Ther (2010) 1.35
Clinical effectiveness of a rehabilitation program integrating exercise, self-management, and active coping strategies for chronic knee pain: a cluster randomized trial. Arthritis Rheum (2007) 1.34
Isolation and characterization of dominant female sterile mutations of Drosophila melanogaster. II. Mutations on the second chromosome. Genetics (1989) 1.33
Chondrosarcoma of the pelvis: oncologic and functional outcome. Sarcoma (2000) 1.32
Evidence for cytokine mediation of disease expression in adults experimentally infected with influenza A virus. J Infect Dis (1999) 1.32
Predictors of mortality after acute hip fracture. J Gen Intern Med (1996) 1.31
Surgical treatment of pelvic sarcomas: oncologic and functional outcome. Clin Orthop Relat Res (2001) 1.31
Microdeletions including YWHAE in the Miller-Dieker syndrome region on chromosome 17p13.3 result in facial dysmorphisms, growth restriction, and cognitive impairment. J Med Genet (2009) 1.31
Intensity of vascular endothelial growth factor expression is associated with increased risk of recurrence and decreased disease-free survival in papillary thyroid cancer. Surgery (2001) 1.29
Superantigen-induced CD4 T cell tolerance mediated by myeloid cells and IFN-gamma. J Immunol (2000) 1.28
Mevalonic aciduria--an inborn error of cholesterol and nonsterol isoprene biosynthesis. N Engl J Med (1986) 1.27
Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis. Diabetes (1999) 1.26
Spontaneous regression of human melanoma/nonmelanoma skin cancer: association with infiltrating CD4+ T cells. World J Surg (1995) 1.26
Deletion of 7q31.1 supports involvement of FOXP2 in language impairment: clinical report and review. Am J Med Genet A (2007) 1.26
Comparison of latex agglutination and immunofluorescence for direct Lancefield grouping of streptococci from blood cultures. J Clin Microbiol (1984) 1.25
Systolic blood pressure, diabetes and the risk of cardiovascular diseases in the Asia-Pacific region. J Hypertens (2007) 1.25
Characterization of idiopathic premature ovarian failure. Fertil Steril (1996) 1.24